我们很高兴看到安炎达MAX-001在多项临床前关键参数测试上显示其具备此类潜力,我们也期待MAX-001可以早日进入关键临床测试阶段。” InflamaXPharmaceuticals Announces a Succesful Pre-A Financing Guangzhou, China (& Saint Louis, United States). January 21st, 2025 - InflamaXPharmaceuticals ("InflamaX" or the ...
Sanofi pushes scientific boundaries to develop breakthrough medicines and vaccines. We chase the miracles of science to improve people’s lives.
January 6, 2025 Fighting Fake Medicines: Our Commitment to Patient and Public Health Protection Read the article Your Health December 11, 2024 Mental Health in Multiple Sclerosis: An Unnerving Aspect of the Disease Read the article Your Health ...
Sanofi pushes scientific boundaries to develop breakthrough medicines and vaccines. We chase the miracles of science to improve people’s lives.
Sanofi pushes scientific boundaries to develop breakthrough medicines and vaccines. We chase the miracles of science to improve people’s lives.
Micky D. Tortorella, Founder and CEO of InflamaXPharmaceuticals, stated: "The high concentrations of prostaglandin E2 (PGE2) found in the tumor microenvironment has attracted a lot of attention by academic researchers and the pharmaceutical industry. PGE2 is a metabolite produced by the COX-2 enzym...
Although an increasingly large amount of data exists on the acute and chronic aquatic toxicity of pharmaceuticals, numerous questions still remain. There remains a dearth of information pertaining to the chronic toxicity of bivalves, benthic invertebrates, fish, and endangered species, as well as stud...
biologically active compounds; food additives; functional foods; nutraceuticals and pharmaceuticals; polysaccharides; secondary metabolites; seaweeds Graphical Abstract1. Introduction The demand for food, chemicals, and energy is rising along with the world’s population growth. Since land resources cannot ...
prodrug (14 mg/kg) or CMC 1% (positive control) or NSAIDs (diclofenac or lumiracoxib—pharmacological controls) on cg-induced leukocyte accumulation in peritoneal cavities of mice were evaluated by total and differential cell counts in peritoneal washes collected 4 h after cg (0.3% w/v) i.p...
BOSTON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that Jean-Pierre Sommadossi, PhD, Chief...